These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 26614233

  • 1. Rectal dose constraints for salvage iodine-125 prostate brachytherapy.
    Peters M, Hoekstra CJ, van der Voort van Zyp JR, Westendorp H, van de Pol SM, Moerland MA, Maenhout M, Kattevilder R, van Vulpen M.
    Brachytherapy; 2016; 15(1):85-93. PubMed ID: 26614233
    [Abstract] [Full Text] [Related]

  • 2. Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraints.
    Peters M, van der Voort van Zyp J, Hoekstra C, Westendorp H, van de Pol S, Moerland M, Maenhout M, Kattevilder R, van Vulpen M.
    Radiother Oncol; 2015 Nov; 117(2):262-9. PubMed ID: 26349590
    [Abstract] [Full Text] [Related]

  • 3. Focal or whole-gland salvage prostate brachytherapy with iodine seeds with or without a rectal spacer for postradiotherapy local failure: How best to spare the rectum?
    Guimas V, Quivrin M, Bertaut A, Martin E, Chambade D, Maingon P, Mazoyer F, Cormier L, Créhange G.
    Brachytherapy; 2016 Nov; 15(4):406-411. PubMed ID: 27317949
    [Abstract] [Full Text] [Related]

  • 4. Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer.
    Hsu CC, Hsu H, Pickett B, Crehange G, Hsu IC, Dea R, Weinberg V, Gottschalk AR, Kurhanewicz J, Shinohara K, Roach M.
    Int J Radiat Oncol Biol Phys; 2013 Feb 01; 85(2):370-7. PubMed ID: 22672747
    [Abstract] [Full Text] [Related]

  • 5. Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103.
    Taggar AS, Charas T, Cohen GN, Boonyawan K, Kollmeier M, McBride S, Mathur N, Damato AL, Zelefsky MJ.
    Brachytherapy; 2018 Feb 01; 17(2):251-258. PubMed ID: 29241706
    [Abstract] [Full Text] [Related]

  • 6. Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicity.
    Rose JN, Crook JM, Pickles T, Keyes M, Morris WJ.
    Brachytherapy; 2015 Feb 01; 14(3):342-9. PubMed ID: 25727178
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Late rectal toxicity after image-based high-dose-rate interstitial brachytherapy for postoperative recurrent and/or residual cervical cancers: EQD2 predictors for Grade ≥II toxicity.
    Chopra S, Dora T, Engineer R, Mechanery S, Agarwal P, Kannan S, Ghadi Y, Swamidas J, Mahantshetty U, Shrivastava SK.
    Brachytherapy; 2015 Feb 01; 14(6):881-8. PubMed ID: 26409708
    [Abstract] [Full Text] [Related]

  • 10. Probability of late rectal morbidity in 125I prostate brachytherapy.
    Waterman FM, Dicker AP.
    Int J Radiat Oncol Biol Phys; 2003 Feb 01; 55(2):342-53. PubMed ID: 12527047
    [Abstract] [Full Text] [Related]

  • 11. Dose to the bladder neck is the most important predictor for acute and late toxicity after low-dose-rate prostate brachytherapy: implications for establishing new dose constraints for treatment planning.
    Hathout L, Folkert MR, Kollmeier MA, Yamada Y, Cohen GN, Zelefsky MJ.
    Int J Radiat Oncol Biol Phys; 2014 Oct 01; 90(2):312-9. PubMed ID: 25304791
    [Abstract] [Full Text] [Related]

  • 12. Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes.
    Chen CP, Weinberg V, Shinohara K, Roach M, Nash M, Gottschalk A, Chang AJ, Hsu IC.
    Int J Radiat Oncol Biol Phys; 2013 Jun 01; 86(2):324-9. PubMed ID: 23474112
    [Abstract] [Full Text] [Related]

  • 13. Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results.
    Mahal BA, Ziehr DR, Hyatt AS, Neubauer-Sugar EH, O'Farrell DA, O'Leary MP, Steele GS, Niedermayr TR, Beard CJ, Martin NE, Orio PF, D'Amico AV, Devlin PM, Nguyen PL.
    Brachytherapy; 2014 Jun 01; 13(5):442-9. PubMed ID: 24880584
    [Abstract] [Full Text] [Related]

  • 14. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
    Mbeutcha A, Chauveinc L, Bondiau PY, Chand ME, Durand M, Chevallier D, Amiel J, Kee DL, Hannoun-Lévi JM.
    Radiat Oncol; 2017 Mar 09; 12(1):49. PubMed ID: 28274241
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. High-dose-rate brachytherapy boost for prostate cancer: Analysis of dose-volume histogram parameters for predicting late rectal toxicity.
    Chicas-Sett R, Farga D, Perez-Calatayud MJ, Celada F, Roldan S, Fornes-Ferrer V, Ibanez-Rosello B, Tormo A, Benlloch JM, Perez-Calatayud J.
    Brachytherapy; 2017 Mar 09; 16(3):511-517. PubMed ID: 28366276
    [Abstract] [Full Text] [Related]

  • 19. A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526).
    Crook JM, Zhang P, Pisansky TM, Trabulsi EJ, Amin MB, Bice W, Morton G, Pervez N, Vigneault E, Catton C, Michalski J, Roach M, Beyer D, Jani A, Horwitz E, Donavanik V, Sandler H.
    Int J Radiat Oncol Biol Phys; 2019 Feb 01; 103(2):335-343. PubMed ID: 30312717
    [Abstract] [Full Text] [Related]

  • 20. Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time.
    Kollmeier MA, McBride S, Taggar A, Anderson E, Lin M, Pei X, Weiji S, Voros L, Cohen G, Yamada Y, Zelefsky MJ.
    Brachytherapy; 2017 Feb 01; 16(6):1091-1098. PubMed ID: 28838648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.